Arin McKinley

1.8k total citations · 1 hit paper
7 papers, 1.1k citations indexed

About

Arin McKinley is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Hematology. According to data from OpenAlex, Arin McKinley has authored 7 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Gastroenterology and 4 papers in Hematology. Recurrent topics in Arin McKinley's work include Gastrointestinal Tumor Research and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). Arin McKinley is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Sarcoma Diagnosis and Treatment (2 papers). Arin McKinley collaborates with scholars based in United States, Belgium and Australia. Arin McKinley's co-authors include Michael C. Heinrich, Diana Griffith, Jonathan A. Fletcher, George D. Demetri, Amy Harlow, Christopher L. Corless, Ajia Town, Ajia Presnell, Robert G. Maki and Xin Huang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Arin McKinley

7 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

2008 564 citations Michael C. Heinrich, Robert G. Maki et al. Journal of Clinical Oncology profile →

Peers

Arin McKinley

PRM

GASTR

SURGE

NEURO

MB

Darrel P. Cohen United States

Gina Z. D’Amato United States

Troy Bainbridge United States

Lori Rink United States

Pierre‐Paul Bringuier France

Yanzhi Hsu United States

Vanessa Tassell United States

Ajia Presnell United States

Helene Geddert Germany

Joanna Gale United Kingdom

Darrel P. Cohen United States

Arin McKinley

788 ×1.1

PRM

621 ×0.9

GASTR

261 ×1.0

SURGE

210 ×0.9

NEURO

288 ×1.6

MB

Citations per year, relative to Arin McKinley Arin McKinley (= 1×) peers Darrel P. Cohen

Countries citing papers authored by Arin McKinley

Since Specialization

Citations

This map shows the geographic impact of Arin McKinley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arin McKinley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arin McKinley more than expected).

Fields of papers citing papers by Arin McKinley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arin McKinley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arin McKinley. The network helps show where Arin McKinley may publish in the future.

Co-authorship network of co-authors of Arin McKinley

This figure shows the co-authorship network connecting the top 25 collaborators of Arin McKinley. A scholar is included among the top collaborators of Arin McKinley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arin McKinley. Arin McKinley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Serrano, César, Adrián Mariño‐Enríquez, Derrick L. Tao, et al.. (2019). Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours. British Journal of Cancer. 120(6). 612–620. 119 indexed citations

2.

Heinrich, Michael C., Jonathan A. Fletcher, Rana Anjum, et al.. (2013). Use of ponatinib to inhibit kinase mutations associated with drug-resistant gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 31(15_suppl). 10509–10509. 1 indexed citations

3.

Heinrich, Michael C., Diana Griffith, Arin McKinley, et al.. (2012). Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors. Clinical Cancer Research. 18(16). 4375–4384. 170 indexed citations

4.

Heinrich, Michael C., Adrián Mariño‐Enríquez, Ajia Presnell, et al.. (2012). Sorafenib Inhibits Many Kinase Mutations Associated with Drug-Resistant Gastrointestinal Stromal Tumors. Molecular Cancer Therapeutics. 11(8). 1770–1780. 57 indexed citations

5.

Beadling, Carol, Michael C. Heinrich, Andrea Warrick, et al.. (2011). Multiplex Mutation Screening by Mass Spectrometry. Journal of Molecular Diagnostics. 13(5). 504–513. 55 indexed citations

6.

Heinrich, Michael C., Robert G. Maki, Christopher L. Corless, et al.. (2008). Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor. Journal of Clinical Oncology. 26(33). 5352–5359. 564 indexed citations breakdown →

7.

Heinrich, Michael C., Heikki Joensuu, George D. Demetri, et al.. (2008). Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases. Clinical Cancer Research. 14(9). 2717–2725. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact